Gene editing for neurodegenerative diseases-A review

Gene editing for neurodegenerative diseases-A review

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2021.

Detalhes bibliográficos
Autor principal:	Sharna, Anika Islam
Outros Autores:	Chowdhury, Namara Mariam
Formato:	Thesis
Idioma:	English
Publicado em:	Brac University 2023
Assuntos:	Neurodegenerative disease (ND) Alzheimer’s disease (AD) Parkinson’s disease (PD) Amyotrophic Lateral Sclerosis (ALS) Huntington’s disease (HD) Frontotemporal Dementia (FD) Nervous system > Diseases. Gene editing > Technological innovations.
Acesso em linha:	http://hdl.handle.net/10361/19303

Registos relacionados

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
Por: Dey, Manashi
Publicado em: (2024)

Potential treatments for epigenetic dysregulation in neurological diseases
Por: Zaman, Rubaiyat
Publicado em: (2024)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
Por: Mostofa, Golam
Publicado em: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
Por: Tabassum, Nadira
Publicado em: (2024)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
Por: Karmaker, Swastika
Publicado em: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
Por: Key, Nasrin Sultana
Publicado em: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
Por: Shehab, Habibul Mohsin
Publicado em: (2024)

Role of circular RNA in neurological disease
Por: Salsabil, Labiba
Publicado em: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
Por: Islam, Md. Rakibul
Publicado em: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
Por: Bakar, Osama Bin Abu
Publicado em: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
Por: Mahee, Sadique Abdal
Publicado em: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Por: Alim, Abdul
Publicado em: (2023)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
Por: Ishrat, Nowshin
Publicado em: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
Por: Jahan, Nusrat
Publicado em: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
Por: Annee, Israt Jahan
Publicado em: (2023)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
Por: Aana, Afsara Sumon
Publicado em: (2021)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Por: Chowdhury, Sariya Uzrat
Publicado em: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
Por: Ferdous, Labiba
Publicado em: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
Por: Afsana, Nourin
Publicado em: (2022)

Harnessing exosomes as a drug delivery system for neurodegenerative diseases
Por: Ferdous, Farhana
Publicado em: (2022)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
Por: Tasneem, Sadia
Publicado em: (2021)

A review of Cell-penetrating peptide mediated drug delivery to the brain
Por: Tisha, Zarin Tasnim
Publicado em: (2024)

Emerging therapies of Alzheimer’s disease: a comprehensive review
Por: Tasin, Md Abtahi
Publicado em: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
Por: Rahman, Quazi Ashikur, et al.
Publicado em: (2022)

To control site-specific skin gene expression, autocrine mimics paracrine canonical Wnt signaling and Is activated ectopically in skin disease
Por: Kim, Dongwon, et al.
Publicado em: (2016)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
Por: Rawshan, A. E. Maisha
Publicado em: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
Por: Islam, Md. Irfath
Publicado em: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
Por: Saha, Bithi Rani
Publicado em: (2023)

Treatment options of Parkinson’s disease: How far we are from the cure?
Por: Afreen, Nuraia
Publicado em: (2021)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
Por: Chowdhury, Amal
Publicado em: (2024)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Por: Tamanna, Mst. Taskia
Publicado em: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
Por: Hassan, Md. Muhtaz
Publicado em: (2020)

Infection and communicable diseases /
Por: Brettle, Raymond Patrick
Publicado em: (1984)

The Aids booklet /
Por: Cox, Frank D.
Publicado em: (1999)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
Por: Aziz, Farhin
Publicado em: (2019)

Alzheimer's disease and marriage : an intimate account /
Por: Wright, Lore K.
Publicado em: (1993)

Can bacteria fly? - bacteriological assessment of common fly (Musca domestica) as a potential carrier for public health epidemics
Por: Tabassum, Nuzhat, et al.
Publicado em: (2024)

Detection of amyotrophic lateral sclerosis using signal processing and machine learning
Por: Ali, Zohair Mehtab
Publicado em: (2020)

Detection of Parkinson’s disease from Neuro-imagery using deep neural network with transfer learning
Por: Asaduzzaman, et al.
Publicado em: (2021)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
Por: Nayeem, Abdullah Al
Publicado em: (2021)